MX9200214A - Producto farmaceutico que comprende granisetron y dexametasona. - Google Patents

Producto farmaceutico que comprende granisetron y dexametasona.

Info

Publication number
MX9200214A
MX9200214A MX9200214A MX9200214A MX9200214A MX 9200214 A MX9200214 A MX 9200214A MX 9200214 A MX9200214 A MX 9200214A MX 9200214 A MX9200214 A MX 9200214A MX 9200214 A MX9200214 A MX 9200214A
Authority
MX
Mexico
Prior art keywords
dexametasone
pharmaceutical product
product including
granisetron
including granisetron
Prior art date
Application number
MX9200214A
Other languages
English (en)
Inventor
Gareth John Sanger
Christopher Stuart Dott
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MX9200214A publication Critical patent/MX9200214A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX9200214A 1991-01-19 1992-01-17 Producto farmaceutico que comprende granisetron y dexametasona. MX9200214A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919101221A GB9101221D0 (en) 1991-01-19 1991-01-19 Pharmaceuticals

Publications (1)

Publication Number Publication Date
MX9200214A true MX9200214A (es) 1992-08-01

Family

ID=10688722

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9200214A MX9200214A (es) 1991-01-19 1992-01-17 Producto farmaceutico que comprende granisetron y dexametasona.

Country Status (12)

Country Link
EP (1) EP0567498A1 (es)
JP (1) JP3521143B2 (es)
KR (1) KR930702991A (es)
AU (1) AU658169B2 (es)
CA (1) CA2100777C (es)
GB (1) GB9101221D0 (es)
IE (1) IE920148A1 (es)
MX (1) MX9200214A (es)
NZ (1) NZ241337A (es)
PT (1) PT100033B (es)
WO (1) WO1992012716A1 (es)
ZA (1) ZA92343B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
US20060263421A1 (en) * 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea
WO2008103852A1 (en) * 2007-02-21 2008-08-28 Victory Pharma, Inc. Transdermal delivery of dexamethasone and promethazine
JP5537104B2 (ja) * 2009-09-16 2014-07-02 テルモ株式会社 制吐剤
KR101368587B1 (ko) * 2010-12-27 2014-03-05 주식회사 삼양바이오팜 오심 또는 구토 방지용 조성물
CN103222977A (zh) * 2013-05-22 2013-07-31 南京工业大学 一种格拉司琼和地塞米松复方经皮控释贴剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3687080T2 (de) * 1985-04-27 1993-03-25 Beecham Group Plc Azabicyclononyl-indazol-carboxamid mit 5-ht-antagonistischer wirkung.
GB8805269D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
AU658169B2 (en) 1995-04-06
NZ241337A (en) 1994-07-26
WO1992012716A1 (en) 1992-08-06
GB9101221D0 (en) 1991-02-27
AU1164192A (en) 1992-08-27
PT100033A (pt) 1993-02-26
KR930702991A (ko) 1993-11-29
CA2100777C (en) 2003-08-19
JPH06507152A (ja) 1994-08-11
CA2100777A1 (en) 1992-07-20
ZA92343B (en) 1992-12-30
PT100033B (pt) 1999-09-30
JP3521143B2 (ja) 2004-04-19
EP0567498A1 (en) 1993-11-03
IE920148A1 (en) 1992-07-29

Similar Documents

Publication Publication Date Title
MX9200798A (es) Producto absorbente.
FI934914A (fi) Farmaceutiska formuleringar
FI921060A (fi) Farmaceutiska aerosolformuleringar
FI922958A (fi) Farmaceutisk sammansaettning
NL350021I1 (nl) 3-Aryl-4-hydroxy-delta3-dihydrofuranon- en 3-aryl-4-hydroxy-delta3-dihydrothiofenon-derivaten.
FI922316A (fi) Farmaceutisk sammansaettning
NO923127D0 (no) Farmasoeytisk kombinasjonsformulering
DK0616523T3 (da) Lægemidler
DE69206378D1 (de) Patientenliegetische.
ITRM920237A1 (it) Perfezionato impiego di medicinali broncodilatatori b2.
NO923859D0 (no) Medikament
PT551048E (pt) Derivados de 2-imidazolina-5-ona e 2-imidazolina-5-tionas fungicidas
MX9102701A (es) Derivados de 2-acilamido de 3,4-dihidro-3-oxo-quinoxalina que tienen actividad farmaceutica.
DZ1559A1 (fr) Compositions pharmaceutiques.
HU00207A9 (en) Sulfonanilide derivatives and medicine
MX9201848A (es) Antiserotoninas, procedimiento para su preparacion y medicamentos que las contienen.
MX9200214A (es) Producto farmaceutico que comprende granisetron y dexametasona.
FI923371A0 (fi) En farmaceutisk formulation.
MX9205375A (es) Nuevos derivados de bencilamina y el medicamento que los contienen.
FR2685698B1 (fr) Derives de la benzofuranylimidazole ainsi que leur procede de preparation.
KR930008430U (ko) 한약 추출기
ATE93197T1 (de) Abschliessbare dose.
MX9204164A (es) Composicion farmaceutica que comprende arndh.
IT9048026A0 (it) Preparato farmaceutico e/o cosmetico.
NO179907C (no) Benzokinoksaliner og farmasöytiske preparater inneholdende de samme